ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Pulmonary Disease

Top Pulmonary Disease Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HAMED ALI MD

Pulmonary Disease

686

$124K

119
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 57%

$180
Average prescription price

Avg: $178

GINA MERRITT D.O.

Pulmonary Disease

675

$147K

109
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 57%

$218
Average prescription price

Avg: $178

LESA LEWANDOWSKI PAC

Pulmonary Disease

665

$113K

145
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 57%

$170
Average prescription price

Avg: $178

JERRY HUNG MD

Pulmonary Disease

665

$139K

143
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 57%

$209
Average prescription price

Avg: $178

BARTON SCHNEYER MD

Pulmonary Disease

660

$112K

118
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 57%

$170
Average prescription price

Avg: $178

STEPHEN GRINTON M.D.

Pulmonary Disease

660

$148K

141
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 57%

$224
Average prescription price

Avg: $178

SAJEEV VETTICHIRA MD

Pulmonary Disease

639

$248K

129
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 57%

$388
Average prescription price

Avg: $178

RAYMOND COAKLEY MD

Pulmonary Disease

630

$382K

38
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 57%

$606
Average prescription price

Avg: $178

JAMES SMITH MD

Pulmonary Disease

630

$92.7K

98
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$147
Average prescription price

Avg: $178

ROBERT CHIN MD

Pulmonary Disease

597

$447K

97
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

86%
prescriptions for brand name drugs

Avg: 57%

$749
Average prescription price

Avg: $178

SEVER SURDULESCU MD

Pulmonary Disease

597

$115K

152
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 57%

$192
Average prescription price

Avg: $178

MITCHELL LEE MD

Pulmonary Disease

593

$208K

140
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 57%

$351
Average prescription price

Avg: $178

ROBERT SHAW M.D.

Pulmonary Disease

574

$85.9K

106
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$150
Average prescription price

Avg: $178

RICHARD POMERANTZ MD

Pulmonary Disease

566

$203K

83
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 57%

$359
Average prescription price

Avg: $178

DALE GREEN MD

Pulmonary Disease

551

$69.3K

38
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$126
Average prescription price

Avg: $178

JUSTIN SWARTZ MD

Pulmonary Disease

548

$74.6K

91
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$136
Average prescription price

Avg: $178

HUBERT FORD M.D.

Pulmonary Disease

546

$806K

68
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

78%
prescriptions for brand name drugs

Avg: 57%

$1476
Average prescription price

Avg: $178

THAW SINT MD

Pulmonary Disease

538

$64.1K

107
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$119
Average prescription price

Avg: $178

MICHAEL REIF MD

Pulmonary Disease

537

$116K

85
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 57%

$216
Average prescription price

Avg: $178

RODOLFO PASCUAL MD

Pulmonary Disease

525

$867K

52
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 57%

$1651
Average prescription price

Avg: $178

JAMES MCCARRICK M.D.

Pulmonary Disease

474

$65.4K

102
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$138
Average prescription price

Avg: $178

THOMAS STERN M.D.

Pulmonary Disease

452

$55.6K

78
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 57%

$123
Average prescription price

Avg: $178

VICTOR ORTEGA M.D.

Pulmonary Disease

451

$153K

40
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 57%

$339
Average prescription price

Avg: $178

HARVEY MARSHALL M.D.

Pulmonary Disease

435

$65.1K

58
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 57%

$150
Average prescription price

Avg: $178

LAKE MORRISON MD

Pulmonary Disease

404

$45.6K

67
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 57%

$113
Average prescription price

Avg: $178

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank